{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:40:59Z","timestamp":1794397259323,"version":"4.9.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,12,11]],"date-time":"2003-12-11T00:00:00Z","timestamp":1071100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation has been implicated in the pathogenesis of Parkinson's disease (PD). In the chronic 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine (MPTP) model of PD, inducible NO synthase (iNOS) derived nitric oxide (NO) is an important mediator of dopaminergic cell death. Ligands of the peroxisome proliferator\u2010activated receptor (PPAR) exert anti\u2010inflammatory effects. We here investigated whether pioglitazone, a PPAR\u03b3 agonist, protected mice from MPTP\u2010induced dopaminergic cell loss, glial activation, and loss of catecholamines in the striatum. As shown by western blot, PPAR\u03b3 was expressed in the striatum and the substantia nigra of vehicle\u2010 and MPTP\u2010treated mice. Oral administration of 20\u2003mg\/(kg\u2003day) of pioglitazone protected tyrosine hydroxylase (TH)\u2010positive substantia nigra neurons from death induced by 5\u2003\u00d7\u200330\u2003mg\/kg MPTP. However, the decrease of dopamine in the striatum was only partially prevented. In mice treated with pioglitazone, there were a reduced activation of microglia, reduced induction of iNOS\u2010positive cells and less glial fibrillary acidic protein positive cells in both striatum and substantia nigra pars compacta. In addition, treatment with pioglitazone almost completely blocked staining of TH\u2010positive neurons for nitrotyrosine, a marker of NO\u2010mediated cell damage. Because an increase in inhibitory protein\u2010\u03ba\u2010B\u03b1 (I\u03baB\u03b1) expression and inhibition of translocation of the nuclear factor kappaB (NF\u03baB) subunit p65 to the nucleus in dopaminergic neurons, glial cells and astrocytes correlated with the protective effects of pioglitazone, our results suggest that pioglitazone sequentially acts through PPAR\u03b3 activation, I\u03baB\u03b1 induction, block of NF\u03baB activation, iNOS induction and NO\u2010mediated toxicity. In conclusion, treatment with pioglitazone may offer a treatment opportunity in PD to slow the progression of disease that is mediated by inflammation.<\/jats:p>","DOI":"10.1046\/j.1471-4159.2003.02210.x","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T06:46:44Z","timestamp":1279262804000},"page":"494-501","source":"Crossref","is-referenced-by-count":326,"title":["Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I\u03baB\u03b1 induction and block of NF\u03baB and iNOS activation"],"prefix":"10.1111","volume":"88","author":[{"given":"Thomas","family":"Dehmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dichgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,12,11]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/376167a0"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.53.082901.104018"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.137.10.4189"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.1.8536636"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00990.x"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/83336"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.40.25573"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.2.978"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0742213.x"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004045200"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.5.2508"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251341998"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.4.784"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10206"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01166-X"},{"key":"e_1_2_13_18_1","volume-title":"The Mouse Brain in Stereotaxic Coordinates.","author":"Franklin K. B. J.","year":"1996"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00928.x"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00703-1"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0996-1017"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00192-7"},{"key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator\u2010activated receptor\u2010gamma ligands reduce neuronal inducible nitric oxide synthase and cell death in vivo","volume":"20","author":"Heneka M. T.","year":"2000","journal-title":"J. Neurosci."},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.14.7531"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/34184"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)02480-0"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.6.3406"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.12.1.335"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.13.4699-4707.2000"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/70978"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0197-20"},{"key":"e_1_2_13_33_1","first-page":"29","article-title":"Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys","volume":"47","author":"Maeshiba Y.","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)00967-5"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.49.34621"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.8.4668"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.10.4565"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/34178"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64020936.x"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.9.4844"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200104170-00037"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.25.5628"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10364-1"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(98)01362-9"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1471-4159.2003.02210.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1471-4159.2003.02210.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:12:38Z","timestamp":1697062358000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1471-4159.2003.02210.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,11]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1046\/j.1471-4159.2003.02210.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02210.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,11]]}}}